"In December 2019, the Phase 3 trial in advanced heart failure surpassed the number of primary endpoint events required for trial completion".
So we've had a trial for Advanced Heart Failure. End-Stage sounds like another category, closer to death. Chronic probably covers both these. Just disappointing that mid-2020 becomes late-2020 for the read out. At some stage their withholding material information from shareholders, which I am thinking means the results are marginal at best. I'll have to do more research tonight.
Ann: Annual Financial Results Presentation, page-34
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.020(1.87%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.11 | $1.07 | $4.338M | 3.980M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 13222 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 61499 | 3 |
View Market Depth
| Last trade - 16.10pm 13/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.020 ( 1.42 %) |
||||
| Open | High | Low | Volume | ||
| $1.08 | $1.11 | $1.07 | 875231 | ||
| Last updated 15.59pm 13/06/2024 ? | |||||
| MSB (ASX) Chart |